Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Robert Wapenaar"'
Autor:
Luis Puig, Antonio Costanzo, Elke M. G. J. de Jong, Tiago Torres, Richard B. Warren, Robert Wapenaar, Sven Wegner, Patricia Gorecki, Talia Gramiccia, Maria Jazra, Jozefien Buyze, Curdin Conrad
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 9, Pp 2539-2558 (2024)
Abstract Introduction The interleukin-23p19 subunit inhibitor, guselkumab, has demonstrated improvements in clinical and patient-reported outcome (PRO) measures in patients with moderate-to-severe psoriasis. Understanding the relationship among clini
Externí odkaz:
https://doaj.org/article/ab526a4a99574512a77a238ef4a81a03
Autor:
Anders Bjartell, Luis Costa, Gero Kramer, Bogdan Zurawski, Luca Galli, Patrick Werbrouck, Thorsten Ecke, Omi Parikh, Mostefa Bennamoun, Camilo Garcia Freire, Avivit Peer, Börje Ljungberg, Irfan Cicin, Emma Smith, Martin Lukac, Robert Wapenaar, Simon Chowdhury
Publikováno v:
European Urology Open Science, Vol 45, Iss , Pp 12-22 (2022)
Background: Prostate cancer has a multifaceted treatment pattern. Evidence is lacking for optimal treatment sequences for metastatic castration-resistant prostate cancer (mCRPC). Objective: To increase the understanding of real-world treatment pathwa
Externí odkaz:
https://doaj.org/article/653632de34f8429eb4ec99b1a412de53
Autor:
Ann Janssens, Zwi N. Berneman, Fritz Offner, Sylvia Snauwaert, Philippe Mineur, Gaetan Vanstraelen, Stef Meers, Isabelle Spoormans, Dominique Bron, Isabelle Vande Broek, Charlotte Van Bogaert, Birgit De Beleyr, Ann Smet, Lasse Nielsen, Robert Wapenaar, Marc André
Publikováno v:
Clinical Hematology International, Vol 4, Iss 4, Pp 133-143 (2022)
Abstract The multicenter observational BiRD study investigated the real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL) and Waldenström’s macroglobulinemia (WM) in Belgium
Externí odkaz:
https://doaj.org/article/246e8f0b6ff948258a81b9155851b6fa
Autor:
Caroline Dartigeas, Borhane Slama, Margaret Doyle, Christoph Tapprich, Claire Albrecht, Sandrine Dupuis, Robert Wapenaar, Charlotte Schmidt-Hieber, Veronique Leblond
Publikováno v:
Clinical Hematology International, Vol 4, Iss 3, Pp 65-74 (2022)
Abstract The FIRE study investigated the real-world effectiveness and safety of ibrutinib in prospectively observed patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and mantle cell lymphoma (MCL) in France. Patients w
Externí odkaz:
https://doaj.org/article/a1c7626872d6438d82dd956185a4915a
Autor:
Maria-Victoria Mateos, Katja Weisel, Valerio De Stefano, Hartmut Goldschmidt, Michel Delforge, Mohamad Mohty, Michele Cavo, Ravi Vij, Joanne Lindsey-Hill, Dominik Dytfeld, Emanuele Angelucci, Aurore Perrot, Reuben Benjamin, Niels W. C. J. van de Donk, Enrique M. Ocio, Christof Scheid, Francesca Gay, Wilfried Roeloffzen, Paula Rodriguez-Otero, Annemiek Broijl, Anna Potamianou, Caline Sakabedoyan, Maria Semerjian, Sofia Keim, Vadim Strulev, Jordan M. Schecter, Martin Vogel, Robert Wapenaar, Tonia Nesheiwat, Jesus San-Miguel, Pieter Sonneveld, Hermann Einsele, Philippe Moreau
Publikováno v:
Leukemia, 36(5), 1371-1376. Nature Publishing Group
Mateos, M-V, Weisel, K, de Stefano, V, Goldschmidt, H, Delforge, M, Mohty, M, Cavo, M, Vij, R, Lindsey-Hill, J, Dytfeld, D, Angelucci, E, Perrot, A, Benjamin, R, van de Donk, N W C J, Ocio, E M, Scheid, C, Gay, F, Roeloffzen, W, Rodriguez-Otero, P, Broijl, A, Potamianou, A, Sakabedoyan, C, Semerjian, M, Keim, S, Strulev, V, Schecter, J M, Vogel, M, Wapenaar, R, Nesheiwat, T, San-Miguel, J, Sonneveld, P, Einsele, H & Moreau, P 2022, ' LocoMMotion : a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma ', Leukemia, vol. 36, no. 5, pp. 1371-1376 . https://doi.org/10.1038/s41375-022-01531-2
Mateos, M-V, Weisel, K, de Stefano, V, Goldschmidt, H, Delforge, M, Mohty, M, Cavo, M, Vij, R, Lindsey-Hill, J, Dytfeld, D, Angelucci, E, Perrot, A, Benjamin, R, van de Donk, N W C J, Ocio, E M, Scheid, C, Gay, F, Roeloffzen, W, Rodriguez-Otero, P, Broijl, A, Potamianou, A, Sakabedoyan, C, Semerjian, M, Keim, S, Strulev, V, Schecter, J M, Vogel, M, Wapenaar, R, Nesheiwat, T, San-Miguel, J, Sonneveld, P, Einsele, H & Moreau, P 2022, ' LocoMMotion : a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma ', Leukemia, vol. 36, no. 5, pp. 1371-1376 . https://doi.org/10.1038/s41375-022-01531-2
Despite treatment advances, patients with multiple myeloma (MM) often progress through standard drug classes including proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs), and anti-CD38 monoclonal antibodies (mAbs). LocoMMotion (ClinicalTrial
Autor:
Michel Delforge, Philippe Moreau, Hermann Einsele, Valerio De Stefano, Joanne Lindsey-Hill, Laure Vincent, Silvia Mangiacavalli, Aurore Perrot, Enrique Ocio, Silene ten Seldam, Ester in ’t Groen-Damen, Maria Semerjian, Vadim Strulev, Jordan Schecter, Tito Roccia, Katharine Gries, Tonia Nesheiwat, Robert Wapenaar, María-Victoria Mateos, Katja Weisel
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S166-S167
Autor:
William Tillett, Sarah Ohrndorf, Julio Ramírez, Marlies Neuhold, Robert Wapenaar, Elke Theander, Christine Contre, Mohamed Sharaf, May Shawi, Marijn Vis
Publikováno v:
Rheumatology. 61
Background/Aims Guselkumab (GUS), a human monoclonal antibody targeting the interleukin-23p19-subunit, has demonstrated efficacy at Week 24 (W24) in the Phase IIIb COSMOS clinical trial of patients with active psoriatic arthritis (PsA) and inadequate
Autor:
Caroline Dartigeas, Borhane Slama, Margaret Doyle, Christoph Tapprich, Claire Albrecht, Sandrine Dupuis, Robert Wapenaar, Charlotte Schmidt-Hieber, Veronique Leblond
Publikováno v:
Clinical hematology international. 4(3)
The FIRE study investigated the real-world effectiveness and safety of ibrutinib in prospectively observed patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and mantle cell lymphoma (MCL) in France. Patients were mostl
Autor:
Hermann Einsele, Philippe Moreau, Valerio De Stefano, Dominik Dytfeld, Emanuele Angelucci, Reuben Benjamin, Hartmut Goldschmidt, Niels W.C.J. van de Donk, Britta Besemer, Christof Scheid, Ravi Vij, Ester in ’t Groen-Damen, Maria Semerjian, Vadim Strulev, Jordan Schecter, Tito Roccia, Tonia Nesheiwat, Robert Wapenaar, Katja Weisel, María-Victoria Mateos
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S169
Autor:
Michel Delforge, Philippe Moreau, Hermann Einsele, Valerio De Stefano, Joanne Lindsey-Hill, Laure Vincent, Silvia Mangiacavalli, Aurore Perrot, Enrique Ocio, Silene ten Seldam, Ester in ’t Groen-Damen, Maria Semerjian, Vadim Strulev, Jordan Mark Schecter, Tito Roccia, Katharine S. Gries, Tonia Nesheiwat, Robert Wapenaar, Maria-Victoria Mateos, Katja Weisel
Publikováno v:
Journal of Clinical Oncology. 40:8030-8030
8030 Background: Evaluation of patient (pt)-reported outcomes provides insight into how real-life SOC treatments (tx) affect HRQoL for pts with RRMM. LocoMMotion (NCT04035226) is the first prospective, multinational study of real-life SOC in triple-c